Mission 2030: Bayer ’s quest for climate neutrality

One hundred times per week. That ’s how often specially trained Bayer team members used to clean certain stainless-steel vessels as part of a six-month-long drug manufacturing process. The medicine in question is a biotech treatment for people with a rare blood-clotting disorder. The vessels held buffering agents, solutions that are used in the purification process of making Factor VIII, the protein missing in people living with hemophilia A. Cleaning each vessel required significant amounts of…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news